More Articles
Catheter-directed thrombolysis (CDT) is associated with significantly lower short-term mortality rates among submassive pulmonary embolism (PE) patients than anticoagulation alone, according to a new meta-analysis published in the…
Cancer survivors appear to be at significantly higher risk for cardiovascular disease, including heart failure and stroke, according to a …
The U.S. Food and Drug Administration (FDA) has had a busy June, overseeing a…
A new AI-based method to detect plaque erosion using optical coherence tomography (OCT) images offers an opportunity to easily identify a condition that blocks blood flow to the heart and can potentially…
Researchers at the University of Sydney are developing a brand new test that uses blood from a quick pin-prick test to examine a person's risk of heart attack or stroke. …
A Chinese study of over 5,000 high-risk adults, published in …
The Society for Cardiovascular Angiography and Interventions (SCAI) has announced its late-breaking study presentations at its 2022 Scientific Sessions. These key…
Renin-angiotensin-aldosterone system (RAAS) inhibitors can help brain aneurysm patients with high blood pressure reduce their risk of rupture, according to new research published in Hypertension.[1]
…
The U.S. Food and Drug Administration (FDA) has announced that Atrium Medical Corp., a subsidiary of Getinge, is recalling its iCast Covered Stent…
The U.S. Food and Drug Administration (FDA) has been busy in recent weeks,…
In-hospital mortality is improving among high-risk pulmonary embolism (PE) patients, according to new findings published in the American Journal of Cardiology.[1] Systemic thrombolysis (ST) and catheter-directed interventions…
Medtronic has received FDA approval for its IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter to treat patients with peripheral arterial disease (PAD) in the superficial femoral and popliteal…
Abbott Medical is recalling multiple lots of its Dragonfly OpStar optical coherence…
Open abdominal aortic aneurysm (AAA) surgical repair is associated with a higher long-term survival rate than endovascular AAA repair (EVAR), according to a new analysis published in JAMA Network Open.[1]
…
Researchers have developed a new imaging-based technique for removing arterial plaque in patients with atherosclerosis, presenting their findings at the 182nd Meeting of the Acoustical Society…
Empagliflozin, an SGLT2 inhibitor approved by the U.S. Food and Drug Administration for the treatment of type 2 diabetes and…
Teva Pharmaceuticals USA, a New Jersey-based healthcare company focused on the development and distribution of generic medications, has recalled a single lot of its …
Interventional cardiologists and other heart specialists from all over the world traveled to Atlanta this week for SCAI 2022, the 45th annual meeting of the Society for Cardiovascular Angiography and…
Intravascular lithotripsy (IVL), the FDA-cleared technology developed by Shockwave Medical, is associated with better peripheral artery disease (PAD) outcomes after two years than…
In a Series D financing round, Ireland-based vessel closure device company Vivasure raised $23 million to advance clinical development and regulatory approval for its absorbable, patch-based, percutaneous…